292 related articles for article (PubMed ID: 19713307)
1. Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome.
Mollet G; Ratelade J; Boyer O; Muda AO; Morisset L; Lavin TA; Kitzis D; Dallman MJ; Bugeon L; Hubner N; Gubler MC; Antignac C; Esquivel EL
J Am Soc Nephrol; 2009 Oct; 20(10):2181-9. PubMed ID: 19713307
[TBL] [Abstract][Full Text] [Related]
2. Early glomerular filtration defect and severe renal disease in podocin-deficient mice.
Roselli S; Heidet L; Sich M; Henger A; Kretzler M; Gubler MC; Antignac C
Mol Cell Biol; 2004 Jan; 24(2):550-60. PubMed ID: 14701729
[TBL] [Abstract][Full Text] [Related]
3. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
4. Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus.
Kanasaki K; Kanda Y; Palmsten K; Tanjore H; Lee SB; Lebleu VS; Gattone VH; Kalluri R
Dev Biol; 2008 Jan; 313(2):584-93. PubMed ID: 18082680
[TBL] [Abstract][Full Text] [Related]
5. Surprising results following conditional podocyte inactivation.
Pollak MR
J Am Soc Nephrol; 2009 Oct; 20(10):2086-8. PubMed ID: 19762489
[No Abstract] [Full Text] [Related]
6. NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review.
Franceschini N; North KE; Kopp JB; McKenzie L; Winkler C
Genet Med; 2006 Feb; 8(2):63-75. PubMed ID: 16481888
[TBL] [Abstract][Full Text] [Related]
7. Kidney Injury by Variants in the
Frese J; Kettwig M; Zappel H; Hofer J; Gröne HJ; Nagel M; Sunder-Plassmann G; Kain R; Neuweiler J; Gross O
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691124
[TBL] [Abstract][Full Text] [Related]
8. CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation.
Cara-Fuentes G; Araya C; Wei C; Rivard C; Ishimoto T; Reiser J; Johnson RJ; Garin EH
Nefrologia; 2013; 33(5):727-31. PubMed ID: 24089165
[TBL] [Abstract][Full Text] [Related]
9. An inducible mouse model of podocin-mutation-related nephrotic syndrome.
Tabatabaeifar M; Wlodkowski T; Simic I; Denc H; Mollet G; Weber S; Moyers JJ; Brühl B; Randles MJ; Lennon R; Antignac C; Schaefer F
PLoS One; 2017; 12(10):e0186574. PubMed ID: 29049388
[TBL] [Abstract][Full Text] [Related]
10. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
[TBL] [Abstract][Full Text] [Related]
11. A missense mutation in podocin leads to early and severe renal disease in mice.
Philippe A; Weber S; Esquivel EL; Houbron C; Hamard G; Ratelade J; Kriz W; Schaefer F; Gubler MC; Antignac C
Kidney Int; 2008 May; 73(9):1038-47. PubMed ID: 18288100
[TBL] [Abstract][Full Text] [Related]
12. [Structure and function of the glomerular filtration barrier].
Musiał K; Zwolińska D
Pol Merkur Lekarski; 2005 Mar; 18(105):317-20. PubMed ID: 15997642
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
Bertelli R; Ginevri F; Caridi G; Dagnino M; Sandrini S; Di Duca M; Emma F; Sanna-Cherchi S; Scolari F; Neri TM; Murer L; Massella L; Basile G; Rizzoni G; Perfumo F; Ghiggeri GM
Am J Kidney Dis; 2003 Jun; 41(6):1314-21. PubMed ID: 12776285
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis.
Caridi G; Bertelli R; Carrea A; Di Duca M; Catarsi P; Artero M; Carraro M; Zennaro C; Candiano G; Musante L; Seri M; Ginevri F; Perfumo F; Ghiggeri GM
J Am Soc Nephrol; 2001 Dec; 12(12):2742-2746. PubMed ID: 11729243
[TBL] [Abstract][Full Text] [Related]
15. Broadening the spectrum of diseases related to podocin mutations.
Caridi G; Bertelli R; Di Duca M; Dagnino M; Emma F; Onetti Muda A; Scolari F; Miglietti N; Mazzucco G; Murer L; Carrea A; Massella L; Rizzoni G; Perfumo F; Ghiggeri GM
J Am Soc Nephrol; 2003 May; 14(5):1278-86. PubMed ID: 12707396
[TBL] [Abstract][Full Text] [Related]
16. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis.
Vincenti F; Ghiggeri GM
Am J Transplant; 2005 Jun; 5(6):1179-85. PubMed ID: 15888021
[TBL] [Abstract][Full Text] [Related]
17. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
Kim EY; Roshanravan H; Dryer SE
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718
[TBL] [Abstract][Full Text] [Related]
18. The genetic basis of FSGS and steroid-resistant nephrosis.
Pollak MR
Semin Nephrol; 2003 Mar; 23(2):141-6. PubMed ID: 12704574
[TBL] [Abstract][Full Text] [Related]
19. In vivo expression of podocyte slit diaphragm-associated proteins in nephrotic patients with NPHS2 mutation.
Zhang SY; Marlier A; Gribouval O; Gilbert T; Heidet L; Antignac C; Gubler MC
Kidney Int; 2004 Sep; 66(3):945-54. PubMed ID: 15327385
[TBL] [Abstract][Full Text] [Related]
20. Podocin and beta dystroglycan expression to study podocyte-podocyte and basement membrane matrix connections in adult protienuric states.
Shankar PB; Nada R; Joshi K; Kumar A; Rayat CS; Sakhuja V
Diagn Pathol; 2014 Feb; 9():40. PubMed ID: 24559085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
